HKU Scholars Hub: Browsing DSpace

Browsing by Author Gianni, L

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中

or enter first few letters:

Showing results 1 to 3 of 3

	Title	Author(s)	Issue Date
	2 years versus 1 year of adjuvant trastuzumab for HER2-positive breast cancer (HERA): an open-label, randomised controlled trial Journal:The Lancet	Goldhirsch, A Gelber, RD Piccart-Gebhart, MJ de Azambuja, E Procter, M Suter, TM Jackisch, C Cameron, D Weber, HA Heinzmann, D Lago, LD McFadden, E Dowsett, M Untch, M Gianni, L Bell, R Köhne, CH Vindevoghel, A Andersson, M Brunt, AM Otero-Reyes, D Song, S Smith, I Leyland-Jones, B Baselga, J Kwong, A	2013
	Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast Cancer Journal:New England Journal of Medicine	Piccart-Gebhart, MJ Procter, M Leyland-Jones, B Goldhirsch, A Untch, M Smith, I Gianni, L Baselga, J Bell, R Jackisch, C Cameron, D Dowsett, M Barrios, CH Steger, G Huang, CS Andersson, M Inbar, M Lichinitser, M Láng, I Nitz, U Iwata, H Thomssen, C Lohrisch, C Suter, TM Rüschoff, J Sütő, T Greatorex, V Ward, C Straehle, C McFadden, E Dolci, S Gelber, RD Herceptin Adjuvant (HERA) Trial Study Team Kwong, A	2005
	Treatment With Trastuzumab For 1 Year After Adjuvant Chemotherapy In Patients With Her2-positive Early Breast Cancer: A 4-year Follow-up Of A Randomised Controlled Trial Journal:The Lancet Oncology	Gianni, L Dafni, U Gelber, RD Azambuja, E Muehlbauer, S Goldhirsch, A Untch, M Smith, I Baselga, J Jackisch, C Cameron, D Mano, M Pedrini, JL Veronesi, A Mendiola, C Pluzanska, A Semiglazov, V Vrdoljak, E Eckart, MJ Shen, Z Skiadopoulos, G Procter, M Pritchard, KI Piccart-Gebhart, MJ Bell, R Kwong, A	2011

Showing results 1 to 3 of 3